Considering the effect of CD4+ CTLs in suppressing other cancers, including melanoma, breast cancer, bladder cancer, and colorectal cancer via their cytotoxicity, whether the dual role of CD4+ CTLs we found in this study is specific to OSCC needs to be verified in the future. This evidence concerns the gene CD4 and breast carcinoma.